Aliases & Classifications for Dysphagia

MalaCards integrated aliases for Dysphagia:

Name: Dysphagia 54 29 55 6
Deglutition Disorders 73

Classifications:



External Ids:

ICD10 33 R13
UMLS 73 C0011168

Summaries for Dysphagia

NINDS : 54 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Dysphagia, also known as deglutition disorders, is related to ptosis and myopathy, and has symptoms including abdominal pain, constipation and diarrhea. An important gene associated with Dysphagia is MEGF10 (Multiple EGF Like Domains 10). The drugs Lansoprazole and Menthol have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and tongue, and related phenotype is cellular.

Wikipedia : 76 Dysphagia is the medical term for the symptom of difficulty in swallowing. Although classified under... more...

Related Diseases for Dysphagia

Diseases related to Dysphagia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 392)
# Related Disease Score Top Affiliating Genes
1 ptosis 28.9 PABPN1 POLG
2 myopathy 28.1 MEGF10 PABPN1 PIK3C2A POLG
3 myopathy, areflexia, respiratory distress, and dysphagia, early-onset 12.4
4 odontoma-dysphagia syndrome 12.3
5 dysphagia lusoria 12.3
6 plummer vinson syndrome 11.9
7 opitz-gbbb syndrome 11.6
8 oculopharyngeal muscular dystrophy 11.4
9 swallowing disorders 11.3
10 jackhammer esophagus 11.1
11 chronic progressive external ophthalmoplegia 11.1
12 aspiration pneumonia 11.1
13 opitz gbbb syndrome, type ii 11.1
14 esophagitis, eosinophilic, 1 11.0
15 esophageal tuberculosis 11.0
16 aberrant subclavian artery 11.0
17 amyotrophic lateral sclerosis 1 11.0
18 myasthenia gravis 11.0
19 niemann-pick disease, type c1 11.0
20 central pontine myelinolysis 10.9
21 thiamine metabolism dysfunction syndrome 2 10.8
22 chromosome 1p36 deletion syndrome 10.8
23 striatonigral degeneration, infantile 10.8
24 neurodegeneration with brain iron accumulation 3 10.8
25 spinal and bulbar muscular atrophy, x-linked 1 10.7
26 spastic paralysis, infantile-onset ascending 10.7
27 myoclonus, intractable, neonatal 10.7
28 laryngeal tuberculosis 10.7
29 mitochondrial neurogastrointestinal encephalopathy disease 10.7
30 achalasia, familial esophageal 10.7
31 leber optic atrophy and dystonia 10.7
32 leukodystrophy, hypomyelinating, 15 10.7
33 primary familial brain calcification 10.7
34 achalasia-microcephaly syndrome 10.7
35 leigh syndrome 10.7
36 fazio-londe disease 10.7
37 adolescent-onset dystonia of mixed type 10.7
38 extrapontine myelinolysis 10.7
39 muscular dystrophy, limb-girdle, type 1a 10.7
40 spinocerebellar ataxia 27 10.7
41 anaplastic thyroid cancer 10.7
42 harding ataxia 10.7
43 scapuloperoneal syndrome, neurogenic, kaeser type 10.7
44 cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss 10.7
45 pura syndrome 10.7
46 spinocerebellar ataxia 13 10.7
47 cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss 10.7
48 pontocerebellar hypoplasia, type 6 10.7
49 thyroglossal duct cyst, familial 10.7
50 neurodegeneration with brain iron accumulation 4 10.7

Graphical network of the top 20 diseases related to Dysphagia:



Diseases related to Dysphagia

Symptoms & Phenotypes for Dysphagia

UMLS symptoms related to Dysphagia:


abdominal pain, constipation, diarrhea, dyspepsia, flatulence, eructation, and gas pain, headache, heartburn, icterus, nausea, nausea and vomiting, seizures, signs and symptoms, digestive, vomiting, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, digestive system symptom, choking sensation, gastrointestinal gas, symptom as reason for upper g.i. examination, pseudobulbar signs, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase

MGI Mouse Phenotypes related to Dysphagia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.1 KIF5A MEGF10 PABPN1 PIK3C2A POLG SLC52A3

Drugs & Therapeutics for Dysphagia

Drugs for Dysphagia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 590)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 103577-45-3 3883
2
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 2216-51-5 16666
3
Methylene blue Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 61-73-4
4
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
5
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 51-61-6, 62-31-7 681
6
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 73590-58-6 4594
7
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-84-3 187
8
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 102625-70-7 4679
9
Acetaminophen Approved Phase 4,Phase 3,Not Applicable 103-90-2 1983
10
Cetuximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 205923-56-4 56842117 2333
11
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Not Applicable 55-56-1 9552079 2713
12
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 117976-89-3 5029
13
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 57808-66-9 3151
14
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 437-38-7 3345
15
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 138530-94-6, 103577-45-3 9578005
16
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-21-8 3385
17
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 90566-53-3 62924
18
Alginic acid Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 9005-32-7
19
Benzydamine Approved Phase 4 100-46-9, 642-72-8 7504
20
Remifentanil Approved Phase 4 132875-61-7 60815
21
Famotidine Approved Phase 4,Phase 2,Phase 3,Not Applicable 76824-35-6 3325
22
Nizatidine Approved Phase 4,Phase 3 76963-41-2 3033637
23
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 2180-92-9, 38396-39-3 2474
24
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 5281106 54677470
25
Budesonide Approved Phase 4,Phase 2,Phase 3 51333-22-3 63006 5281004
26
Nortriptyline Approved Phase 4,Phase 2,Phase 3 72-69-5 4543
27
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
28
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Phase 3 15307-86-5 3033
29
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
30
Morphine Approved, Investigational Phase 4,Not Applicable 57-27-2 5288826
31
Rocuronium Approved Phase 4,Early Phase 1 119302-91-9, 143558-00-3 441290
32
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
33
Ranitidine Approved Phase 4,Phase 3,Phase 2,Not Applicable 66357-59-3, 66357-35-5 3001055
34
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
35
Propranolol Approved, Investigational Phase 4 525-66-6 4946
36
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
37
Metoclopramide Approved, Investigational Phase 4,Phase 3,Not Applicable 364-62-5 4168
38
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
39
Pectin Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 9000-69-5 441476
40
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
41
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 2078-54-8 4943
42
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 75614-87-8, 51-45-6 774
43
Oxybutynin Approved, Investigational Phase 4,Phase 3 5633-20-5 4634
44
Benzocaine Approved, Investigational Phase 4,Phase 3,Not Applicable 1994-09-7, 94-09-7 2337
45
Ethanol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 64-17-5 702
46
Epinephrine Approved, Vet_approved Phase 4,Not Applicable 51-43-4 5816
47
Nystatin Approved, Vet_approved Phase 4 1400-61-9 11953884
48
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
49
Aluminum hydroxide Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 21645-51-2
50
Polidocanol Approved Phase 4,Not Applicable 9002-92-0

Interventional clinical trials:

(show top 50) (show all 1531)
# Name Status NCT ID Phase Drugs
1 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
2 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
3 Evaluation of Low-level Laser at Auriculotherapy Points to Reduce Postoperative Pain in Inferior Third Molar Surgery Unknown status NCT02657174 Phase 4
4 Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants. Unknown status NCT02806453 Phase 4
5 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4 omeprazole+domperidone SR;omeprazole
6 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
7 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Unknown status NCT01503476 Phase 4
8 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
9 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
10 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4 sodium alginate;esomeprazole
11 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
12 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
13 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
14 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
15 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
16 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
17 Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia Completed NCT01081444 Phase 4
18 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
19 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
20 Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain Completed NCT02322346 Phase 4 Group LL;Group HL
21 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Completed NCT00528541 Phase 4
22 Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis Completed NCT03323528 Phase 4 Benzalkonium Chloride-Benzocaine Topical;Placebo Oral Tablet
23 Acetaminophen's Efficacy For Post-operative Pain Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
24 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4 Omeprazole;Famotidine
25 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4 naloxone;remifentanil;Sodium Chloride;metoclopramide
26 To Evaluate the Effect of Chlorhexidine-benzidamine Administration Completed NCT03253497 Phase 4 Chlorobenzene Liquid
27 Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers Completed NCT01924234 Phase 4 Morphine;Remifentanil
28 WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture Completed NCT01699542 Phase 4
29 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
30 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
31 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
32 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4 Tacrolimus (Arm B);Clotrimazole Troche;Tacrolimus (Arm A);Nystatin Suspension
33 An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis Completed NCT01008696 Phase 4 Rabeprazole;Lansoprazole
34 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) Completed NCT00872755 Phase 4
35 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Completed NCT00641602 Phase 4 Esomeprazole;Lansoprazole
36 PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Completed NCT01893541 Phase 4 PROPRANOLOL
37 Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Completed NCT01851863 Phase 4 Omeprazole;Flupentixol-Melitracen(psychological and GI) + Omeprazole;Flupentixol-Melitracen(psychological) + Omeprazole;Flupentixol-Melitracen(without explanation) + Omeprazole
38 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
39 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4 Lansoprazole
40 Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) Completed NCT00431041 Phase 4 solifenacin;oxybutynin immediate release
41 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4 Esomeprazole
42 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4 Meloxicam;Diclofenac;Nimesulide
43 Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults Completed NCT03154515 Phase 4 Ingavirin;Placebo
44 Comparison Between the I-gel and the LMA-Unique Completed NCT02163486 Phase 4
45 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4 Dexlansoprazole
46 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
47 A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study Completed NCT02049112 Phase 4
48 Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B Completed NCT03128736 Phase 4 Esomeprazole group;Dexlansoprazole group
49 The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity Completed NCT02958046 Phase 4 Lansoprazole/Domperidone
50 The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity Completed NCT02689999 Phase 4 Dexrabeprazole 10 mg Enteric-Coated Tablets

Search NIH Clinical Center for Dysphagia

Genetic Tests for Dysphagia

Genetic tests related to Dysphagia:

# Genetic test Affiliating Genes
1 Dysphagia 29

Anatomical Context for Dysphagia

MalaCards organs/tissues related to Dysphagia:

41
Lung, Testes, Tongue, Brain, Thyroid, Bone, Colon

Publications for Dysphagia

Articles related to Dysphagia:

(show top 50) (show all 1197)
# Title Authors Year
1
Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. ( 29389984 )
2018
2
Dysphagia due to macroglossia in a patient with amyloidosis associated with multiple myeloma: A case report. ( 29889980 )
2018
3
Severe, reversible dysphagia and malnutrition in a patient with tumour-induced hypophosphataemia. ( 29950359 )
2018
4
Structural airway abnormalities contribute to dysphagia in children with esophageal atresia and tracheoesophageal fistula. ( 29429770 )
2018
5
Risk factors for dysphagia after a spinal cord injury: a systematic review and meta-analysis. ( 29955090 )
2018
6
Pediatric laryngeal cleft repair and dysphagia. ( 29287871 )
2018
7
Solitary anterior osteochondroma of cervical spine: An unusual cause of dysphagia and review of literature. ( 29928094 )
2018
8
Conus medullaris arteriovenous malformation presenting with acute dysphagia and intractable hiccups. ( 29305117 )
2018
9
An unusual cause of dysphagia in a child: Gastrointestinal manifestations of epidermolysis bullosa. ( 29923525 )
2018
10
Corrigendum: Image of the month: Dysphagia due to injury of the corticobulbar tract following traumatic brain injury. ( 29436459 )
2018
11
Pre-stroke undiagnosed dysphagia lusoria as a rare cause of aspiration pneumonia with respiratory failure in a stroke patient. ( 29552342 )
2018
12
The surgical management of dysphagia secondary to diffuse idiopathic skeletal hyperostosis. ( 29438856 )
2018
13
Dysphagia lusoria: a little-known cause of dysphagia. ( 29368939 )
2018
14
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. ( 29399642 )
2018
15
One-Year Risk of Pneumonia and Mortality in Patients with Poststroke Dysphagia: A Nationwide Population-Based Study. ( 29395642 )
2018
16
Clinical course and outcome in patients with severe dysphagia after lateral medullary syndrome. ( 29511384 )
2018
17
Aspiration Pneumonia as a Cause of Death in Critically Ill Patients with Dysphagia After Extubation. ( 29538126 )
2018
18
Dual Transcranial Direct Current Stimulation for Poststroke Dysphagia: A Randomized Controlled Trial. ( 29926772 )
2018
19
Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomia. ( 29196937 )
2018
20
A rare cause of dysphagia: Pyriform sinus atypical lipomatous tumor. ( 29940678 )
2018
21
Tuberculous Paraspinal Abscess Invading Esophagus: A Rare Cause of Dysphagia. ( 29950266 )
2018
22
International consensus (ICON) on assessment of oropharyngeal dysphagia. ( 29396225 )
2018
23
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer. ( 29948260 )
2018
24
Prevalence, Nature, and Management of Oral Stage Dysphagia in Adults With Temporomandibular Joint Disorders: Findings From an Irish Cohort. ( 29549021 )
2018
25
Effects of a swallowing exercise education program on dysphagia-specific health-related quality of life in oral cavity cancer patients post-treatment: a randomized controlled trial. ( 29546525 )
2018
26
Feeding experiences of nursing aides for residents with dysphagia. ( 29398011 )
2018
27
Creation and Initial Validation of the International Dysphagia Diet Standardisation Initiative Functional Diet Scale. ( 29428348 )
2018
28
Dysphagia Management in Iran: Knowledge, Attitude and Practice of Healthcare Providers. ( 29931606 )
2018
29
Introducing a Virtual Lesion Model of Dysphagia Resulting from Pharyngeal Sensory Impairment. ( 29402815 )
2018
30
Determining peak cough flow cut-off values to predict aspiration pneumonia among patients with dysphagia using the citric acid reflexive cough test. ( 29981313 )
2018
31
Dysphagia and associated clinical markers in neurologically intact children with respiratory disease. ( 29393599 )
2018
32
Which Provocation Test Will Be Added to Routine High-resolution Manometry Protocol in Unexplained Dysphagia? ( 29969853 )
2018
33
Dysphagia lusoria: uncommon cause of dysphagia in children. ( 29931991 )
2018
34
The impact of the difference in O-C2 angle in the development of dysphagia after occipitocervical fusion: a simulation study in normal volunteers combined with a case-control study. ( 29410299 )
2018
35
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment. ( 29978259 )
2018
36
Diagnostic accuracy of lip force and tongue strength for sarcopenic dysphagia in older inpatients: A cross-sectional observational study. ( 29398338 )
2018
37
Prevalence and association of oral candidiasis with dysphagia in individuals with acquired brain injury. ( 29182379 )
2018
38
Frequency and outcome of post-extubation dysphagia using nurse-performed swallowing screening protocol. ( 29968309 )
2018
39
Quantitative Risk Factor Analysis of Post-Operative Dysphagia After Anterior Cervical Discectomy and Fusion (ACDF) using the Eating Assessment Tool-10 (EAT-10). ( 29965886 )
2018
40
Short-Term Effects of Cold Liquids on the Pharyngeal Swallow in Preterm Infants with Dysphagia: A Pilot Study. ( 29435661 )
2018
41
Orofacial strength, dysarthria, and dysphagia in Congenital Myotonic Dystrophy. ( 29901230 )
2018
42
Cervical Hyperostosis Leading to Dyspnea, Aspiration and Dysphagia: Strategies to Improve Patient Management. ( 29740589 )
2018
43
The Dysphagia in Stroke Protocol Reduces Aspiration Pneumonia in Patients with Dysphagia Following Acute Stroke: a Clinical Audit. ( 29603057 )
2018
44
Oral phase dysphagia in facial onset sensory and motor neuronopathy. ( 29781209 )
2018
45
Interdisciplinary Telemedicine in the Management of Dysphagia in Head and Neck. ( 29404691 )
2018
46
Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. ( 29961581 )
2018
47
Reversible dysphagia secondary to guttural pouch mycosis in a gelding treated medically with voriconazole and surgically with carotid occlusion and esophagostomy. ( 29386677 )
2018
48
Esophageal transit time in patients with chagasic megaesophagus: Lack of linear correlation between dysphagia and grade of dilatation. ( 29517674 )
2018
49
Dysphagia in myasthenia gravis: the tip of the Iceberg. ( 29417423 )
2018
50
Migration of endovascular plug in hybrid repair of dysphagia lusoria. ( 29942904 )
2018

Variations for Dysphagia

ClinVar genetic disease variations for Dysphagia:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 ZGRF1 NM_018392.4(ZGRF1): c.3596_3597delCT (p.Ser1199Cysfs) deletion Uncertain significance rs1057518892 GRCh38 Chromosome 4, 112587460: 112587461
2 ZGRF1 NM_018392.4(ZGRF1): c.3596_3597delCT (p.Ser1199Cysfs) deletion Uncertain significance rs1057518892 GRCh37 Chromosome 4, 113508616: 113508617
3 DNMT1 NM_001130823.2(DNMT1): c.2718C> G (p.Phe906Leu) single nucleotide variant Uncertain significance rs1057518774 GRCh38 Chromosome 19, 10148886: 10148886
4 DNMT1 NM_001130823.2(DNMT1): c.2718C> G (p.Phe906Leu) single nucleotide variant Uncertain significance rs1057518774 GRCh37 Chromosome 19, 10259562: 10259562

Expression for Dysphagia

Search GEO for disease gene expression data for Dysphagia.

Pathways for Dysphagia

GO Terms for Dysphagia

Sources for Dysphagia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....